Cystic fibrosis telemedicine in the era of COVID-19.

Autor:	Rad EJ; Chest Clinic, Stanford Health Care, Stanford, California, USA., Mirza AA; Department of Medicine, Stanford University School of Medicine, Stanford, California, USA., Chhatwani L; Department of Medicine, Stanford University School of Medicine, Stanford, California, USA., Purington N; Department of Medicine, Stanford University, Stanford, California, USA., Mohabir PK; Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.
Jazyk:	angličtina
Zdroj:	JAMIA open [JAMIA Open] 2022 Feb 09; Vol. 5 (1), pp. ooac005. Date of Electronic Publication: 2022 Feb 09 (Print Publication: 2022).
DOI:	10.1093/jamiaopen/ooac005
Abstrakt:	The coronavirus disease 2019 pandemic has resulted in large-scale changes to incorporate telemedicine for the delivery of care. People with cystic fibrosis (CF) have care considerations that pose challenges to telemedicine; they include frequent visits for pulmonary disease progression, medication management, and evaluation by a multidisciplinary team of providers. We share our center's experience with video visits replacing in-person clinic evaluation, using quality improvement strategies to create a replicable workflow. Key considerations include incorporation of the multidisciplinary team into the visit, limitations of remote delivery of care, as well as patient and staff perceptions of this care model. Results revealed that video visits were convenient, efficacious, and comparable to in-person visits, with interest for its continued incorporation into the traditional CF care model. (© The Author(s) 2022. Published by Oxford University Press on behalf of the American Medical Informatics Association.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu